baclofen has been researched along with Pervasive Child Development Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, CA | 1 |
| Veenstra-Vanderweele, JM | 1 |
| Melmed, RD | 1 |
| McCracken, JT | 1 |
| Ginsberg, LD | 1 |
| Sikich, L | 1 |
| Scahill, L | 1 |
| Cherubini, M | 1 |
| Zarevics, P | 1 |
| Walton-Bowen, K | 1 |
| Carpenter, RL | 1 |
| Bear, MF | 1 |
| Wang, PP | 1 |
| King, BH | 1 |
| Hopkins, CR | 1 |
1 review available for baclofen and Pervasive Child Development Disorders
| Article | Year |
|---|---|
ACS chemical neuroscience molecule spotlight on STX209 (arbaclofen).
Topics: Animals; Baclofen; Child; Child Development Disorders, Pervasive; Clinical Trials, Phase II as Topic | 2011 |
1 trial available for baclofen and Pervasive Child Development Disorders
| Article | Year |
|---|---|
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
Topics: Adolescent; Akathisia, Drug-Induced; Baclofen; Child; Child Development Disorders, Pervasive; Female | 2014 |